Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2391-2405
Open Access | Times Cited: 9112

Showing 1-25 of 9112 citing articles:

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
Blood (2016) Vol. 129, Iss. 4, pp. 424-447
Open Access | Times Cited: 5146
WHO classification of tumours of haematopoietic and lymphoid tissues
Daniel Bell, Frank Gaillard
Radiopaedia.org (2010)
Open Access | Times Cited: 3699
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner, Andrew H. Wei, Frederick R. Appelbaum, et al.
Blood (2022) Vol. 140, Iss. 12, pp. 1345-1377
Open Access | Times Cited: 1774
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1676
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 310-320
Open Access | Times Cited: 1597
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus, Michele Baccarani, Richard T. Silver, et al.
Leukemia (2020) Vol. 34, Iss. 4, pp. 966-984
Open Access | Times Cited: 1230
‘Acute myeloid leukemia: a comprehensive review and 2016 update’
Ivan de Kouchkovsky, Maher Abdul‐Hay
Blood Cancer Journal (2016) Vol. 6, Iss. 7, pp. e441-e441
Open Access | Times Cited: 1140
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner, Cristina E. Tognon, Daniel Bottomly, et al.
Nature (2018) Vol. 562, Iss. 7728, pp. 526-531
Open Access | Times Cited: 1137
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T Terwilliger, Maher Abdul‐Hay
Blood Cancer Journal (2017) Vol. 7, Iss. 6, pp. e577-e577
Open Access | Times Cited: 1092
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
David B. Beck, Marcela A. Ferrada, Keith A. Sikora, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 27, pp. 2628-2638
Open Access | Times Cited: 842
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver, Richard F. Schlenk, Nigel H. Russell, et al.
Leukemia (2019) Vol. 33, Iss. 2, pp. 299-312
Open Access | Times Cited: 810
Prediction of acute myeloid leukaemia risk in healthy individuals
Sagi Abelson, Grace Collord, Stanley Ng, et al.
Nature (2018) Vol. 559, Iss. 7714, pp. 400-404
Open Access | Times Cited: 741
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis, Rong Wang, Amy J. Davidoff, et al.
Blood Reviews (2019) Vol. 36, pp. 70-87
Closed Access | Times Cited: 709
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. Coleman Lindsley, Wael Saber, Brenton G. Mar, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 6, pp. 536-547
Open Access | Times Cited: 682
Acute myeloid leukaemia
Nicholas J. Short, Michael Rytting, Jorge E. Cortés
The Lancet (2018) Vol. 392, Iss. 10147, pp. 593-606
Open Access | Times Cited: 664
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud, et al.
Journal of the National Comprehensive Cancer Network (2017) Vol. 15, Iss. 7, pp. 926-957
Open Access | Times Cited: 617
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent, Cem Akin, Dean D. Metcalfe
Blood (2016) Vol. 129, Iss. 11, pp. 1420-1427
Open Access | Times Cited: 616
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Andrew H. Wei, Pau Montesinos, Vladimir Ivanov, et al.
Blood (2020) Vol. 135, Iss. 24, pp. 2137-2145
Open Access | Times Cited: 607
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 543
Pediatric acute lymphoblastic leukemia
Hiroto Inaba, Charles G. Mullighan
Haematologica (2020) Vol. 105, Iss. 11, pp. 2524-2539
Open Access | Times Cited: 534
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker, Róbert Královics
Blood (2016) Vol. 129, Iss. 6, pp. 667-679
Open Access | Times Cited: 531
Acute lymphoblastic leukaemia
Florent Malard, Mohamad Mohty
The Lancet (2020) Vol. 395, Iss. 10230, pp. 1146-1162
Open Access | Times Cited: 530
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Jacob Grinfeld, Jyoti Nangalia, E. Joanna Baxter, et al.
New England Journal of Medicine (2018) Vol. 379, Iss. 15, pp. 1416-1430
Open Access | Times Cited: 528
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
The Lancet Haematology (2020) Vol. 7, Iss. 10, pp. e737-e745
Open Access | Times Cited: 526
Page 1 - Next Page

Scroll to top